A Primer on Health Economic Evaluations in Thoracic Oncology-Reference-Cited by-同舟云学术

A Primer on Health Economic Evaluations in Thoracic Oncology

Published:2016-08 Issue:8 Volume:11 Page:1224-1232
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Whittington Melanie D.,Atherly Adam J.,Bocsi Gregary T.,Camidge D. Ross

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Medicare Access and CHIP Reauthorization Act of 2015, 114th Congr. (2015–2016). https://www.congress.gov/bill/114th-congress/house-bill/2/text. Published April 16, 2015. Accessed March 21, 2016.

2. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015

3. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options;Schnipper;J Clin Oncol,2015

4. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group;Hoffmann;Health Policy,2000

5. Decision Modelling for Health Economic Evaluation;Briggs,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing time-driven activity-based costing at the national level to support policy recommendations for radiation oncology in Belgium;Journal of Accounting and Public Policy;2023-01

2. Recommendations for Methicillin-Resistant Staphylococcus aureus Prevention in Adult ICUs;Critical Care Medicine;2017-08